This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bisceglie, V. (1933) Uber die antineoplastische immunitat; heterologe Einpflnzung von Tumoren in Huhner-embryonen. Ztschr. Krebsforsch. 40: 122–140.
Chang, T.M.S. (1964) Semipermeable microcapsules. Science 146: 524–525.
Soon-Shiong, P.; Heintz, R.; Merideth, N.; Yao Quiang, X.; Yao, Z. and Zheng, T. (1994) Insulin independence in a type I diabetic patient after encapsulated islet transplantation. Lancet 343: 950–951.
Hasse, C.; Klock, G.; Schlosser, A.; Zimmermann, U. and Rothmund, M. (1997) Parathyroid allotransplantation without immunosuppression. Lancet 351: 1296–1297.
Orive, G.; Hernández, R.M.; Gascón, A.R.; Calafiore, R.; Chang, T.M.S.; De Vos, P.; Hortelano, G.; Hunkeler, D.; LacÍk, I.; Shapiro, A.M.J. and Pedraz, J.L. (2003) Cell encapsulation: promise and progress. Nat. Med. 9: 104–107.
Orive, G.; Hernández, R.M.; Gascón, A.R.; Igartua, M. and Pedraz, J.L. (2002) Controversies over stem cell research. Trends Biotechnol. 20: 382–387.
Aebischer, P.; Schluep, M.; Déglon, N.; Joseph, J.M.; Hirt, L.; Heyd, B.; Goddard, M.; Hammang, J.P.; Zurn, A.D.; Kato, A.C.; Regli, F. and Baetge, E.E. (1996) Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 2: 696–699.
De Vos, P. and Marchetti, P. (2002) Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. Trends Mol. Med. 8: 363–366.
Leoni, L. and Desai, T.A. (2001) Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility. IEEE Trans. Biomed. Eng. 48: 1335–1341.
Scheneider, B.L.; Schwenter, F.; Pralong, W.F. and Aebischer, P. (2003) Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery. Mol. Ther. 7(4): 506–514.
Check, E. (2002) Regulators split on gene therapy as patient shows signs of cancer. Nature 419: 545–546.
Emerich, D.F.; Winn, S.R.; Hantraye, P.M.; Peschanski, M.; Chen, E.Y.; Chu, Y.; McDermott, P.; Baetge, E.E. and Kordower, J.H. (1997) Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington’s disease. Nature 386:395–399.
Lörh, M.; Hoffmeyer, A.; Kröger, J.C.; Freund, M.; Hain, J.; Holle, A.; Karle, P.; Knöfel, W.T.; Liebe, S.; Müller, P.; Nizze, H.; Renner, M.; Saller, R.M.; Wagner, T.; Hauenstein, K.; Günzburg, W.H. and Salmons B. (2001) Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet 2001 357: 1591–1592.
Angelova, N. and Hunkeler, D. (1999) Rationalizing the design of polymeric biomaterials. Trends Biotechnol. 17: 409–421.
Dauvivier-Kali, V.; Omer, A.; Parent, R.J.; O’Neil, J. and Weir, G.C. (2001) Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50: 1698–1705.
Espevik, T.; Otterlei, M.; Skjåk-Bræk, G.; Ryan, L.; Wright, S.D. and Sundan, A. (1993) The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur. J. Immunol. 23: 255–261.
Cole, D.R.; Waterfall, M.; McIntyre, M.; Baird, J.D. (1992) Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Diabetologia 35: 231–237.
De Vos, P.; De Haan, B.J.; Pater, J. and Van Schilfgaarde, R. (1996) Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts. Transplantation 62: 893–899.
Soon-Shiong, P.; Otterlei, M.; Skjåk-Bræk, G.; Smidsrød, O.; Heintz, R.; Lanza, P. and Espevik, T. (1991) An immunology basis for the fibrotic reaction to implanted microcapsules. Transplant. Proc. 23: 758–759.
Clayton, H.A.; London, N.J.; Colloby, P.S.; Bell, P.R. and James, R.F. (1991) The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules. J. Microencapsul. 8: 221–233.
Zimmermann, U.; Klöck, G.; Federlin, K.; Haning, K.; Kowaslski, M.; Bretzel, R.G.; Horcher, A.; Entenmann, H.; Siebers, U. and Zekorn, T. (1992) Production of mitogen contamination free alginates with variable rations of mannuronic to guluronic acid by free flow electrophoresis. Electrophoresis 13: 269–274.
Orive, G.; Ponce, S.; Hernández, R.M.; Gascón, A.R.; Igartua, M. and Pedraz, J.L. (2002) Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates. Biomaterials 23: 3825–3831.
De Vos, P.; De Haan, B.J.; Wolters, G.H.J.; Stubbe, J.H. and Van Schilfgaarde, R. (1997) Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 40: 262–270.
Lim, F. and Sun, A.M. (1980) Microencapsulated islets as bioartificial endocrine pancreas. Science 210: 908–909.
Thu, B.; Bruheim, P.; Espevik, T.; Smidsrød, O.; Soon-Shiong, P. and Skjåk-Bræk, G. (1996) Alginate polycation microcapsules. I. Interaction between alginate and polycation. Biomaterials 17: 1031–1040.
Strand, B.L.; Ryan, L.; Veld, P.I.; Kulseng, B.; Rokstad, A.M.; Skjåk-Bræk, G. and Espevik, T. (2001) Poly-L-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant. 10: 263–275.
King, A.; Sandler, S. and Andersson, A. (2001) The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J. Biomed. Mat. Res. 57: 374–383.
King, A; Strand, B; Rokstad, AM; Kulseng, B; Andersson A; Skjåk-Bræk, G and Sandler S (2003). Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating. J. Biomed. Mat. Res. 64:533–539.
Strand, B.L.; Mørch, Y.A.; Syvertsen, K.R., Espevik, T. and Skjåk-Bræk, G. (2003) Microcapsules made by enzymatically tailored alginate. J. Biomed. Mat. Res. 64: 540–550.
Kong, H.J.; Smith, M.K. and Mooney, D.J. (2003) Designing alginate hydrogels to maintain viability of immobilised cells. Biomaterials 24: 4023–4029.
Rowley, J.A. and Mooney, D.J. (2002) Alginate type and RGD density control myoblast phenotype. J. Biomed. Mat. Res. 60: 217–223.
Luca, G.; Calafiore, R.; Basta, G.; Ricci, M.; Calvitti, M.; Neri, L.; Nastruzzi, C.; Becchetti, E.; Capitani, S.; Brunetti, P. and Rossi, C. (2001) Improved function of rat islets upon co-microencapsulation with Sertoly cells in alginate/poly-L-ornithine. AAPS Pharmasci. Tech. 2(3): 1–7.
Orive, G.; Hernández, R.M.; Gascón, A.R.; Igartua, M. and Pedraz, J.L. (2003) Development and optimisation of alginate-PMCG-alginate microcapsules for cell immobilisation. Int. J. Pharm. 259: 57–68.
Cruise, G.M.; Hegre, O.D.; Lamberti, F.V.; Hager, S.R.; Hill, R.; Scharp, D.S. and Hubbell, J.A. (1999) In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 8: 293–306.
Schneider, S.; Feilin, P.J.; Slotty, V.; Kampfner, D.; Preuss, S.; Berger, S.; Beyer, J. and Pommersheim, R. (2001) Multilayer capsules: a promising microencapsulation system for transplantation of pancreatic islets. Biomaterials 22: 1961–1970.
Risbud, M.V.; Bhargava, S. and Bhonde, R.R. (2003) In vivo biocompatibility evaluation of cellulose macrocapsules for islet immunoisolation: implications of low molecular weight cut-off. J. Biomed. Mat. Res. 66: 86–92.
Kobayashi, T.; Aomatsu, Y.; Iwata, H.; Kin, T.; Kanehiro, H.; Hisanaga, M.; Ko, S.; Nagao, M. and Nakajima, Y. (2003) Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression. Transplantation 75(5): 619–625.
Murphy, F.A. (1996) The public health risk of animal organ and tissue transplantation into humans. Science 273: 746–747.
Orive, G.; Hernández, R.M.; Gascón, A.R.; Igartua, M. and Pedraz, J.L. (2003) Survival of different cell lines in alginate-agarose microcapsules. Eur. J. Pharm. Sci. 18:23–30.
Sommer, B.; Rinsch, C.; Payen, E.; Dalle, B.; Schneider, B.; Déglon, N.; Henri, A.; Beuzard, Y. and Aebischer, P. (2002) Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts. Mol. Ther. 6(2): 155–161.
Folkman, J. (1989) What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82: 4–6.
Kim, K.J.; Li, B.; Winer, J.; Armanini, M.; Gillet, N.; Phillips, H.S. and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841–844.
Millauer, B.; Schwner, L.K.; Plate, K.H.; Risau, W. and Ullrich, A. (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576–579.
Cirone; P.; Bourgeois, M. and Chang, P.L. (2003) Antiangiogenic cancer therapy with microencapsulated cells. Hum. Gene Ther. 14: 1065–1077.
Read, T.A.; Sorensen, D.R.; Mahesparan, R.; Enger, P.Ø.; Timpl, R.; Olsen, B.R.; Hjelstuen, H.B.; Haraldseth, O. and Bjerkvig, R. (2001) Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat. Biotechnol. 19: 29–34.
Joki, T.; Machluf, M.; Atala, A.; Zhu, J.; Seyfried, N.T.; Dunn, I.F.; Abe, T.; Carroll, R.S.; Black, P.McL. (2001) Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat. Biotechnol. 19: 35–39.
Orive, G.; Hernández, R.M.; Gascón, A.R.; Igartua, M.; Rojas, A. and Pedraz, J.L. (2001) Microencapsulation of an anti VE-cadherin antibody secreting 1B5 hybridoma cells. Biotechnol. Bioeng. 76: 285–294.
Bach, T.L.; Barsigian, C.; Chalupowich, D.G.; Busler, D.; Yaen, C.H.; Grant, D.S. and Martinez, J. (1998) VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp. Cell Res. 238: 324–334.
Xu, W.; Liu, L. and Charles, I.G. (2002) Microencapsulated iNOS-expressing cells cause tumor suppression in mice. FASEB J. 16: 213–215.
Lörh, M.; Hummel, F.; Faulmann, G.; Ringel, J.; Saller, R.; Hain, J.; Günzburg, W.H. and Salmons, B. (2002) Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor: the magic bullets of the 21st century. Cancer Chemother. Pharmacol. 49(1): 21–24.
Cirone, P.; Bourgeois, M.; Austin, R.C. and Chang, P.L. (2002) A novel approach to tumor suppression with microencapsulated recombinant cells. Hum. Gene Ther. 13: 1157–1166.
Hillgärtner, M.; Zimmermann, H.; Mimietz, S.; Jork, A.; Thürmer, F.; Scheneider, H.; Nöth, U. and Hasse, C. (1999) Immunoisolation of transplants by entrapment in 19F-labelled alginic gels: production, biocompatibility, stability, and long-term monitoring of functional integrity. Mat. Wiss. U. Werkstofftech. 30: 783–792.
De Vos, P.; Van Hoogmoed, C.G.; De Haan, B.J. and Busscher, H.J. (2002) Tissue responses against immunoisolating alginate-PLL-alginate capsules in the immediate posttransplant period. J. Biomed. Mat. Res. 62:430–437.
Zimmermann, H.; Hillgärtner, M.; Manz, B.; Feilen, P.; Brunnenmeineier, F.; Leinfelder, U.; Weber, M.; Cramer, H.; Schneider, S.; Hendrich, C.; Volke, F. and Zimmermann, U. (2003) Fabrication of homogeously cross-linked, functional alginate microcapsules validated by NMR-, CLSM-and AFMimaging. Biomaterials 24(12): 2083–2096.
Leinfelder, U.; Brunnenmeier, F.; Cramer, H.; Schiller, J.; Arnold, K.; Vásquez, J.A. and Zimmermann, U. (2003) A highly sensitive cell assay for validation of purification regimes of alginates. Biomaterials 24(23): 4161–4172.
Klemenz, A.; Schwinger, C.; Brandt, J. and Kressler, J. (2003) Investigation of elasto-mechanical properties of alginate microcapsules by scanning acoustic microscopy. J. Biomed. Mat. Res. 65: 237–243.
Van Raamsdonk, J.M. and Chang, P.L. (2000) Osmotic pressure test: A simple, quantitative method to asses the mechanical stability of alginate microcapsules. J. Biomed. Mater. Res. 54: 264–271.
Lewinska, D.; Rosinski, S.; Hunkeler, D.; Poncelet, D. and Werynski, A. (2002) Mass transfer coefficient in characterization of gel beads and microcapsules. J. Memb. Sci. 5409: 1–8.
Bartkowiak, A. and Hunkeler, D. (1999) New microcapsules based on oligoelectrolyte complexation. Ann. NY Acad. Sci. 875: 36–45.
Saller, R.M.; Indraccolo, S.; Coppola, V.; Esposito, G.; Stange, J.; Mitzner, S.; Heinzmann, U.; Amadori, A.; Salmons, B. and Günzburg, W.H. (2002) Encapsulated cells producing retroviral vectors for in vivo gene therapy. J. Gene Med. 4: 150–160.
Peduto, G.; Rinsch, C.; Schneider, B.L.; Rolland, E. and Aebischer, P. (2000) Long-term unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression. Transplantation 70: 78–85.
Ross, C.J.D. and Chang, P.L. (2002) Development of small alginate microcapsules for recombinant gene product delivery to the brain. J. Biomat. Sci. Polym. Edit. 13: 953–962.
(2002) U.S.Pharmacopeia and National Formulary 1046: 2762–2790.
Orive, G.; Hernández, R.M.; Gascón, A.R.; Igartua, M. and Pedraz, J.L. (2003) Cell microencapsulation technology for biomedical purposes: novel insights and challenges. Trends Pharm. Sci. 24(5): 207–210.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer
About this chapter
Cite this chapter
Orive, G., Hernández, R.M., Gascón, A.R., Pedraz, J.L. (2005). Challenges in Cell Encapsulation. In: Nedović, V., Willaert, R. (eds) Applications of Cell Immobilisation Biotechnology. Focus on Biotechnology, vol 8B. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3363-X_10
Download citation
DOI: https://doi.org/10.1007/1-4020-3363-X_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-3229-5
Online ISBN: 978-1-4020-3363-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)